The outlook of companies tied to blockbuster drugs like Viagra presents a challenging investment landscape . While the initial surge of copyright, fueled by Viagra's remarkable popularity, generated substantial returns, the expiry in key markets has introduced significant volatility. Investors are now grappling with the effect of generic competitio